Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7α‐hydroxylase gene expression

Mouse fibroblast growth factor 15 (FGF15) and human ortholog FGF19 have been identified as the bile acid–induced intestinal factors that mediate bile acid feedback inhibition of cholesterol 7α‐hydroxylase gene (C YP7A1) transcription in mouse liver. The mechanism underlying FGF15/FGF19 inhibition of bile acid synthesis in hepatocytes remains unclear. Chenodeoxycholic acid (CDCA) and the farnesoid X receptor (FXR)‐specific agonist GW4064 strongly induced FGF19 but inhibited CYP7A1 messenger RNA (mRNA) levels in primary human hepatocytes. FGF19 strongly and rapidly repressed CYP7A1 but not small heterodimer partner (SHP) mRNA levels. Kinase inhibition and phosphorylation assays revealed that the mitogen‐activated protein kinase/extracellular signal‐regulated kinase 1/2 (MAPK/Erk1/2) pathway played a major role in mediating FGF19 inhibition of CYP7A1. However, small interfering RNA (siRNA) knockdown of SHP did not affect FGF19 inhibition of CYP7A1. Interestingly, CDCA stimulated tyrosine phosphorylation of the FGF receptor 4 (FGFR4) in hepatocytes. FGF19 antibody and siRNA specific to FGFR4 abrogated GW4064 inhibition of CYP7A1. These results suggest that bile acid–activated FXR is able to induce FGF19 in hepatocytes to inhibit CYP7A1 by an autocrine/paracrine mechanism. Conclusion: The hepatic FGF19/FGFR4/Erk1/2 pathway may inhibit CYP7A1 independent of SHP. In addition to inducing FGF19 in the intestine, bile acids in hepatocytes may activate the liver FGF19/FGFR4 signaling pathway to inhibit bile acid synthesis and prevent accumulation of toxic bile acid in human livers. (HEPATOLOGY 2009;49:297‐305.)

[1]  H. Danielsson,et al.  On the regulation of bile acid formation in the rat liver. , 1958, Acta physiologica Scandinavica.

[2]  Masahiro Tohkin,et al.  Targeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis , 2000, Cell.

[3]  C. Blackmore,et al.  Liver-specific Activities of FGF19 Require Klotho beta* , 2007, Journal of Biological Chemistry.

[4]  W. Mckeehan,et al.  Independent Repression of Bile Acid Synthesis and Activation of c-Jun N-terminal Kinase (JNK) by Activated Hepatocyte Fibroblast Growth Factor Receptor 4 (FGFR4) and Bile Acids* , 2005, Journal of Biological Chemistry.

[5]  K. Mitropoulos,et al.  Cholesterol 7 alpha-hydroxylase. , 1977, Journal of lipid research.

[6]  D. French,et al.  Printed in U.S.A. Copyright © 2002 by The Endocrine Society Transgenic Mice Expressing Human Fibroblast Growth Factor-19 Display Increased Metabolic Rate and Decreased Adiposity , 2022 .

[7]  J. Chiang,et al.  Identification and characterization of a putative bile acid-responsive element in cholesterol 7 alpha-hydroxylase gene promoter. , 1994, The Journal of biological chemistry.

[8]  T. A. Kerr,et al.  Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. , 2000, Molecular cell.

[9]  J. Chiang,et al.  Bile acids and cytokines inhibit the human cholesterol 7 alpha-hydroxylase gene via the JNK/c-jun pathway in human liver cells. , 2006, Hepatology.

[10]  J. Chiang,et al.  Bile acids and cytokines inhibit the human cholesterol 7α‐hydroxylase gene via the JNK/c‐jun pathway in human liver cells , 2006 .

[11]  J. Chiang,et al.  Regulation of cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription by the liver orphan receptor (LXRalpha). , 2001, Gene.

[12]  T. Lundåsen,et al.  Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man , 2006, Journal of internal medicine.

[13]  B. Lemon,et al.  Co-receptor Requirements for Fibroblast Growth Factor-19 Signaling* , 2007, Journal of Biological Chemistry.

[14]  J. Chiang,et al.  Mechanism of rifampicin and pregnane X receptor inhibition of human cholesterol 7 alpha-hydroxylase gene transcription. , 2005, American journal of physiology. Gastrointestinal and liver physiology.

[15]  S. Eriksson,et al.  Biliary Excretion of Bile Acids and Cholesterol in Bile Fistula Rats. Bile Acids and Steroids.∗ † , 1957, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[16]  R. Soriano,et al.  Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetes. , 2004, Endocrinology.

[17]  I. Bekersky,et al.  Biochemical site of regulation of bile acid biosynthesis in the rat. , 1970, Journal of lipid research.

[18]  J. Chiang,et al.  Regulation of cholesterol 7α-hydroxylase gene (CYP7A1) transcription by the liver orphan receptor (LXRα) , 2001 .

[19]  J. Chiang,et al.  Identification of a bile acid response element in the cholesterol 7 alpha-hydroxylase gene CYP7A. , 1997, The American journal of physiology.

[20]  G. Ness,et al.  Regulation of cholesterol 7 alpha-hydroxylase by hepatic 7 alpha-hydroxylated bile acid flux and newly synthesized cholesterol supply. , 1991, The Journal of biological chemistry.

[21]  I. Schulman,et al.  Regulation of Complement C3 Expression by the Bile Acid Receptor FXR* , 2005, Journal of Biological Chemistry.

[22]  S. Kliewer,et al.  Liver receptor homolog-1 regulates bile acid homeostasis but is not essential for feedback regulation of bile acid synthesis. , 2008, Molecular endocrinology.

[23]  L. Moore,et al.  A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. , 2000, Molecular cell.

[24]  S. Kliewer,et al.  Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine Published, JLR Papers in Press, August 24, 2007. , 2007, Journal of Lipid Research.

[25]  A. Goddard,et al.  FGF-19, a novel fibroblast growth factor with unique specificity for FGFR4. , 1999, Cytokine.

[26]  Fen Wang,et al.  Increased carbon tetrachloride-induced liver injury and fibrosis in FGFR4-deficient mice. , 2002, The American journal of pathology.

[27]  B. M. Forman,et al.  Farnesoid X receptor protects liver cells from apoptosis induced by serum deprivation in vitro and fasting in vivo. , 2008, Molecular endocrinology.

[28]  P. Hylemon,et al.  Failure of intravenous infusion of taurocholate to down-regulate cholesterol 7 alpha-hydroxylase in rats with biliary fistulas. , 1995, Gastroenterology.

[29]  M. Karin,et al.  Redundant pathways for negative feedback regulation of bile acid production. , 2002, Developmental cell.

[30]  S. Kliewer,et al.  Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis. , 2003, Genes & development.

[31]  J. Chiang.  Regulation of bile acid synthesis: pathways, nuclear receptors, and mechanisms. , 2004, Journal of hepatology.

[32]  J. Auwerx,et al.  Compromised Intestinal Lipid Absorption in Mice with a Liver-Specific Deficiency of Liver Receptor Homolog 1 , 2007, Molecular and Cellular Biology.

[33]  Roger A. Davis,et al.  Bile Acid Induction of Cytokine Expression by Macrophages Correlates with Repression of Hepatic Cholesterol 7α-Hydroxylase* , 2000, The Journal of Biological Chemistry.

[34]  S. Kliewer,et al.  Identification of a hormonal basis for gallbladder filling , 2006, Nature Medicine.

[35]  D. Russell.  The enzymes, regulation, and genetics of bile acid synthesis. , 2003, Annual review of biochemistry.

[36]  S. Kliewer,et al.  Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. , 2005, Cell metabolism.

[37]  S. Kliewer,et al.  Tissue-specific Expression of βKlotho and Fibroblast Growth Factor (FGF) Receptor Isoforms Determines Metabolic Activity of FGF19 and FGF21* , 2007, Journal of Biological Chemistry.

[38]  N. Itoh,et al.  Structure and expression of a novel human FGF, FGF-19, expressed in the fetal brain. , 1999, Biochimica et biophysica acta.

[39]  J. Chiang,et al.  Glucagon and cAMP inhibit cholesterol 7α‐hydroxylase (CYP7a1) gene expression in human hepatocytes: Discordant regulation of bile acid synthesis and gluconeogenesis , 2006, Hepatology.

[40]  D. Russell,et al.  Loss of nuclear receptor SHP impairs but does not eliminate negative feedback regulation of bile acid synthesis. , 2002, Developmental cell.

[41]  C. Deng,et al.  Elevated Cholesterol Metabolism and Bile Acid Synthesis in Mice Lacking Membrane Tyrosine Kinase Receptor FGFR4* , 2000, The Journal of Biological Chemistry.